Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lenvatinib

EU orphan designation number: EU/3/15/1460   
Active ingredient: Lenvatinib
Indication: Treatment of hepatocellular carcinoma
Sponsor: Eisai Europe Limited
European Knowledge Centre, Mosquito Way, Hatfield, Herts AL10 9SN, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2015 Orphan designation EMA/OD/287/14 (2015)2029 of 19/03/2015